Anti-Obesity Hydrogel Tech Absorbs $30m

Gelesis has raised $30m to support the company's activities as it readies its Gelesis100 hydrogel-based anti-obesity treatment for US and EU regulatory approval submissions this year and lays the groundwork for commercialization.